Introduction
Environmental toxins can be grouped loosely as organic or inorganic (i.e. metal-ion-containing) compounds. Man-made organic toxins are often persistent in Nature because their unnatural chemical structures are resistant to existing biochemical mechanisms of detoxification. By contrast, toxic metalion-containing compounds are often naturally occurring, but have been redispersed and concentrated in the environment through human activities. Because of the natural exposure to metal ions, many micro-organisms long ago elaborated mechanisms to avoid their toxicity. The key to these mechanisms is prevention of metal-ion complexation of important functional groups on biomolecules (e.g. proteins and DNA), a goal that has been accomplished in many ways, including sequestration by specific chelators, exportation by specific transporters, and redox conversion to less toxic oxidation states [1] . In this Chapter I will examine Nature's design of the most common detoxification pathway identified for mercuric ion compounds.
Overview of mer operons and roles of proteins
Although some organisms have developed strategies to sequester Hg(II), most employ a redox strategy for detoxification that takes advantage of the physiologically accessible reduction potential for Hg(II) to Hg(0). Being hydrophobic and volatile, Hg(0) can escape from the bacterial cell, leaving it unharmed. The genes encoding this detoxification pathway are frequently organized in regulated operons, but are not always found on plasmids associated with transposons carrying antibiotic-resistance genes. Figure 1 (A) summarizes several operons from both Gram-negative and Gram-positive bacteria [2, 3] . Although the organization varies, common genes in all operons include: merR, which codes for an Hg(II) sensing, DNA-binding, regulatory protein; merA, which codes for the mercuric-ion-reducing protein; and one or more of the genes merP, merT and/or merC, which code for proteins involved in transporting mercuric ions into the cytoplasm of the bacterial cell. Organisms possessing this minimum set of genes exhibit a narrow-spectrum resistance, meaning they can survive in the presence of mercuric-ion compounds with exchangeable ligands. Several operons also contain a gene designated merB, which codes for an organomercurial lyase protein that catalyses the cleavage of covalent C-Hg bonds. Organisms possessing these operons exhibit a broad-spectrum resistance to both organomercurials and mercuric-ion compounds. The additional gene designated merD appears to code for a protein that binds DNA weakly, and may serve a co-regulatory, but non-essential, role. Those genes designated as open reading frames have yet to be functionally characterized.
Assignment of the basic functions for the pathway proteins comes in large part from genetic analyses of mutations and deletions in the Tn21 operon [4] . Subsequent cloning and expression of individual genes, primarily from Tn501, Tn21 and Bacillus sp. RC607, have allowed detailed biochemical analyses of the individual functions of several of the proteins. Figure 1 (B) summarizes the overall cellular organization of the pathway proteins in Gram-negative bacteria. The same organization occurs in Gram-positive bacteria; however, with no outer membrane or periplasmic space, it is unclear whether a secreted MerP is involved. In the sections that follow, our current understanding of the structures and functions of the individual proteins is described. A recurring theme to note is the presence of essential cysteine residues in each of the proteins. This is to be expected, since thiol-containing compounds exhibit the highest affinity for Hg(II) and, in fact, have long been referred to by the generic name mercaptans, meaning mercury capturing.
Regulation of gene expression -merR
As alluded to above, synthesis of the detoxification proteins only occurs when cells are exposed to Hg(II) (or organomercurials in the case of broad-spectrum resistance). As with most inducible pathways, control of protein expression occurs at the level of gene transcription (mRNA synthesis), and involves binding of the protein coded by the merR gene to the operator/promoter region of the mer operon. Extensive studies of the interactions of the MerR proteins from Tn21 and Tn501 with their respective DNA operator/promoter sequences have revealed several unusual features of the interaction [5] . As indicated in Figure 2 (A), the merR gene in these operons is transcribed divergently [2] . Bacterial sources for the top four include: Shigella flexneri and Escherichia coli (Tn21), Pseudomonas aeruginosa (Tn501), Serratia marcescens (pDU1358), and P. stutzeri (pPB). Sequences from Thiobacillus ferrooxidans, Bacillus sp. RC607 and Streptomyces lividans are chromosomally encoded. o/p, operator/promoter region. Adapted in part from [2] , with permission from Elsevier Science, and in part from [3] from the detoxification genes [TP(C)AD]; hence, there are two divergent, but overlapping, promoter sequences, P R and P T , for binding of RNA polymerase (RNAP) and subsequent transcription in opposite directions. Neither promoter has the optimal 17-bp spacing between the RNAP recognition sequences, but transcription from P R is preferred in the absence of the MerR protein. This makes sense because MerR is the Hg(II) sensor and the other proteins are not needed unless the toxin is sensed. MerR binds as a dimer to a symmetrical stretch of DNA between the -35 and -10 RNAP-recognition sequences in the P T promoter. Since this site overlaps the transcriptional start site for the merR gene itself, the MerR protein represses its own transcription as well as that of the detoxification genes.
One unusual feature of the MerR protein-DNA complex is the finding that RNAP still binds to the -35 site of the P T promoter when MerR is present. Although atypical of most repressors, this behaviour is ideal in a detoxification system, because it effectively primes the system for immediate transcription of the detoxification genes at the slightest influx of the highly toxic Hg(II).
A second unusual feature of the protein is that upon binding of the inducer ligand Hg(II), MerR neither dissociates completely from nor moves to a new site on the DNA. Instead, the Hg(II)-MerR complex activates transcription of the detoxification genes while remaining bound at the same location [5] . Adapted with permission from Nature (London) [6] . © (1995) Macmillan Magazines Ltd.
and while still repressing transcription of its own gene. Extensive evidence indicates that it does this by altering the shape of the DNA. In the absence of Hg(II), the MerR dimer induces a double kink in the DNA at its recognition sequences [6] . Binding of Hg(II) alters the protein-DNA interaction just enough to release the bend in the DNA and allow an untwisting or underwinding of the DNA in the suboptimal spacer in the P T promoter. This relaxation of the kink in the DNA, coupled with the underwinding of the spacer, is envisioned to allow the pre-associated RNAP to bind to its -10 recognition site, allowing transcription of the detoxification genes. Figure 2 (B) is a cartoon of this current model for repression and activation [6] .
The remaining feature of the MerR protein to consider is the nature of the Hg(II)-binding site. As the sensor for this highly toxic species, the Hg(II)-binding site is expected to exhibit both high selectivity and high affinity in order to compete with the many binding sites for Hg(II) in the cell. MerR is indeed exquisitely sensitive, activating transcription in vitro with only nanomolar concentrations of Hg(II) in the presence of 10 6 -fold higher concentrations of competing thiol-containing ligands, exactly as needed to compete in the thiol-rich cytoplasm of the bacterial cell. Likewise, the protein shows a 10 2 -10 3 -fold selectivity for Hg(II) over similar metal ions, like Cd(II), Zn(II) and Ag(I) [7] .
How does the protein achieve this high affinity and selectivity? Clearly, cysteine thiols are the expected ligands, but the question is: how many and in what geometry? In solution, linear Hg(II)-dithiol complexes with relatively short Hg-S bonds are most common. Although of high affinity, these also rapidly exchange with other thiols by association/dissociation of a third ligand. With sterically hindered thiol ligands, 3-and 4-co-ordinate Hg(II)-thiol complexes with slightly longer Hg-S bonds are favoured and have higher formation constants overall. This suggests that a higher-affinity Hg(II)-protein complex might utilize more than two cysteines positioned on the semi-rigid scaffold of the protein to optimize the Hg-S bond lengths and geometry for a 3-or 4-co-ordinate complex. In MerR, only one Hg(II) binds per dimer, again the most efficient design, since the dimer is the active DNA-binding unit. Comparison of several MerR protein sequences indicates that three cysteines are completely conserved in the monomers, yielding six cysteines available for the single Hg(II) per dimer. By comparison with the spectral properties of several crystallographically characterized 2-, 3-and 4-co-ordinate Hg-thiol model complexes, O'Halloran and co-workers showed that Hg(II)-MerR is a complex with three cysteine residues [8, 9] . To examine which three participate, Helmann and co-workers generated a series of single, and multiple, Cys→Ala mutations of the three conserved cysteines in the Bacillus RC607 protein [10] . Their studies indicate that Hg(II) forms an asymmetric complex across the dimer interface using one conserved cysteine from one monomer and the other two conserved cysteines from the other monomer. Presumably, formation of this asymmetric Hg(II) complex requires a significant conformational change that drives the observed structural changes in the protein-DNA complex. Elucidation of the disposition of the three cysteines and the nature of the conformational change awaits information on the three-dimensional structures of MerR [ϮHg(II)] and its DNA complex.
Proteins of mercury transport
As illustrated in Figure 1(B) , the actual detoxification step, i.e. reduction of Hg(II) to Hg(0), occurs within the cytoplasm of the bacterial cell and, thus, requires that Hg(II) enter the cell. Non-specific entry of mercuric ions into cells is neither rapid nor high in flux. Thus to avoid the toxic effects of Hg(II) binding to the exterior of cells, each operon codes for at least one protein involved in transporting Hg(II) specifically across the inner cell membrane.
Among the characterized Gram-negative operons, the merT/merP combination is most common and clearly sufficient for resistance. Of this pair, merT codes for an integral membrane protein with two pairs of cysteines, which provides the actual cross-membrane transport, whereas merP codes for a soluble protein with one pair of cysteines and is secreted into the periplasmic space. The merC gene codes for another integral membrane protein that appears to be the sole transport protein in Thiobacillus ferrooxidans. However, deletion of merC in the Tn21 system shows little effect on resistance [11] . A role of enhancing resistance has been suggested based on the higher occurrence of merC genes in bacteria isolated from mercury-polluted sediments [2] . In the Gram-positive operons, the only obvious transport gene is homologous to merT.
The presence of both a periplasmic protein and a transporter in Gram-negative species is reminiscent of nutrient importers, where the functions of the two proteins are highly coupled. In those systems, little or no transport occurs unless the periplasmic protein is present to scavenge the low levels of nutrients and deliver them to the transporter through specific protein-protein interactions. Although a similar role may be envisioned for MerP, the toxicity of Hg(II) suggests that a protective role may be equally or more important. Studies of the Tn501 system suggest that the functions of the two proteins are not highly coupled [12] . Thus when the merT gene is expressed in the absence of any other mer operon genes, the cells become hypersensitive to Hg(II), meaning they die at lower Hg(II) concentrations than cells expressing no mer operon genes. This indicates that transport of Hg(II) into the cell occurs readily in the absence of MerP. When both merP and merT are expressed, the cells are slightly less hypersensitive, consistent with an increased binding capacity for Hg(II) due to the presence of the MerP protein. This suggests a major role for MerP as a scavenger to protect other periplasmic and membrane proteins from binding Hg(II), rather than as an enhancer of transport.
Additional studies using site-directed Cys→Ser mutations of MerP and MerT have provided further insight into their functions and interactions. In MerP, both cysteines are required for specific binding of Hg(II) [13] . In the absence of the first cysteine in the sequence, the second one remains reduced [12, 13] , and the expressed protein inhibits transport in the Tn501 system [12] . This suggests that MerP does specifically interact with MerT to hand off bound Hg(II), even though it is not essential for transport to occur. Structures of MerP have recently been reported {oxidized [14] ; and reduced Ϯ Hg(II) [15] , and see Figure 3} , providing the opportunity to design further mutagenesis studies to probe the specificity determinants for this MerP-MerT interaction. In MerT, there are two pairs of conserved cysteines: the first pair appears in the first of three predicted transmembrane helices, and the second pair is predicted to appear in a cytoplasmic loop. Since nothing is known of the oligomeric state of MerT in the membrane, or whether the two pairs of cysteines in a single monomer could approach one another in three dimensions, the nature of the Hg(II)-binding site(s) is unclear. However, mutation of either Blue dots are the cysteine sulphurs and the black dot is Hg(II). Structures were generated using RasMac v2.6 (freeware) and co-ordinates from Brookhaven Protein Databank files 1afi (model 2) and 1afj (model 7) for the top and bottom structures, respectively.
Cys 14
Hg (II) Cys 17 cysteine in the transmembrane pair to serine leads to complete loss of Hg(II) transport; whereas the second pair appears to be less critical for transport [12] . Further analysis of the role of these residues is needed.
Organomercurial resistance
As described above, broad-spectrum resistance to organomercurials, in addition to mercuric ions, is associated with the presence of only one additional gene, merB, which codes for an organomercurial lyase. Since MerR represses expression of all the detoxification genes, it must also be responsive to organomercurials. Although not extensively studied, it appears that removal of 15-20 of the C-terminal amino acids of MerR from operons containing a merB gene reduces or eliminates resistance to organomercurials, suggesting this portion of MerR may be important for sensing organomercurial compounds [5] . Transport of organomercurials is also not well characterized, but it appears that small hydrophobic organomercurials like methylmercury diffuse non-specifically across the membrane, whereas others, such as phenylmercury, require transport by MerT [16] for efficient flux.
The reaction catalysed by organomercurial lyase involves cleavage of the C-Hg bond to yield a hydrocarbon and a mercuric ion with exchangeable ligands (eqn. 1) that can then serve as a substrate for mercuric ion reductase:
In vitro assays of the lyase require thiol compounds as ligands for activity. The protein is quite promiscuous, accepting aromatic or aliphatic, large or small substrates. This has allowed a fairly thorough study of the stereochemistry and mechanism of C-Hg bond cleavage using a variety of substrates, including several probes for generation of radical intermediates [17] . The results indicate complete retention of stereochemistry and integrity of chemical structure, indicating no formation of radical intermediates in the reaction. Overall, the results are most consistent with an S E 2 (bimolecular electrophilic substitution) mechanism ( Figure 4 ) involving a proton transfer to the incipient carbanion, concomitant with nucleophilic attack at Hg(II) by an enzyme residue. Analysis of several merB sequences indicates there are three highly conserved cysteines in the protein. Site-directed mutagenesis of any of these cysteines to alanine in MerB in the Escherichia coli R831 operon led to a loss of resistance to phenylmercuric acetate, suggesting that all of the cysteines play a role in liganding the R 3 C-HgX substrate and the Hg(II) product before it is released [18] . Although not characterized, it seems likely that the Hg(II) product of the lyase would be transferred directly to mercuric ion reductase in vivo for the final detoxification step.
The key step -Hg(II) reduction
Upon arrival in the cytoplasm, mercuric ions undergo the actual detoxification step, two-electron reduction to elemental mercury. As shown in eqn. 2, NADPH is the source of electrons [19] , and because of the high thiol content of the cell, an Hg-dithiol complex is the expected form of the substrate:
Mercuric ion reductase (MerA), which catalyses the reaction, is a homodimeric enzyme with two interfacial active sites [20] ; see Figure 5 (A). Structurally, it is a homologue of the flavin-disulphide oxidoreductase enzymes [21, 22] , such as glutathione reductase or lipoamide dehydrogenase, which catalyse reversible redox reactions involving NAD(P)H and a disulphide substrate. The common feature of their active sites is the presence of an electron-mediating FAD cofactor sandwiched between the binding site for NAD(P)H and a redoxactive pair of cysteines. In the disulphide reductases, these cysteines cycle between oxidized and reduced states, but in MerA they remain reduced and form part of the Hg(II)-binding site [23] . Unique to MerA is a second pair of cysteines [24] , contributed by the C-terminus of the other monomer, and two tyrosines, one from each monomer, which complete the residues in each Hg(II)-binding site ( Figure 5B ). The presence of multiple cysteines in the Hg(II)-binding sites of MerA is consistent with its need to trap Hg(II); but very tight complexation, as observed in MerR, is not desirable here, since tight complexation would lower the reduction potential to a level that would inhibit reduction of the bound Hg(II). Thus a key mechanistic question is how the enzyme utilizes its cysteines to achieve both jobs of trapping and reducing Hg(II). In vivo, all four cysteines are essential, since mutation of any of them to alanine in the context of the full mer operon yields a physiologically deficient enzyme [25, 26] . In vitro, the defects vary and, in some cases, are dependent on the conditions used to evaluate the mutant. The clearest result is that mutation of either of the redox-active cysteines results in complete loss of rapid Hg(II) reduction under any conditions, indicating that both residues are essential for electron transfer to Hg(II) at catalytically relevant rates, and may be required for formation of the reducible Hg(II) complex [25] . Confirmation of the latter conclusion comes from recent results with the double Cys→Ala mutant of the C-terminal cysteines. This mutant is inactive in steady-state assays where the substrate is a Hg-dithiol complex, as in the cell [26] . However, rapid-reaction studies monitoring the spectral properties of the flavin cofactor show that when the Hg(II) substrate is a complex with smaller and much weaker ligands than thiols (e.g. HgBr 2 ) [27] , the enzyme rapidly forms a Hg(II) complex with the redox-active cysteines that is then reduced at a rate faster than catalytic turnover. Current studies of this mutant using Hg-dithiol complexes indicate a more limited access of these complexes to the active site and, perhaps, an incomplete displacement of the non-enzymic thiol ligands. Comparison with the wild-type enzyme and the single Cys→Ala mutants of the C-terminal cysteines [28] suggests that both C-terminal cysteines are essential for fully displacing the nonenzymic thiol ligands before Hg(II) is transferred to the redox-active cysteines Transfer is via the C-terminal cysteines into a complex with the redox-active cysteine pair, adjacent to the flavin, where reduction can occur. Adapted with permission from [29] . ©(1999) American Chemical Society. for reduction [29] . Thus, our current view is that the predominant role of the C-terminal cysteines is to provide the trapping site for Hg(II), whereas the redox-active cysteines provide the reducible complex of Hg(II) (Figure 6 ). The story, however, is not quite complete there. Extensive evidence indicates that the two active sites in the MerA homodimer exhibit different thermodynamic and kinetic properties in many reactions of ligands with the wild-type and mutant forms of the enzyme. These observations have led to the proposal that the enzyme may function by an alternating-sites mechanism where the properties of the monomers on each dimer are always asymmetric, but alternate in a coupled fashion throughout the reaction [30] . Such a mechanism may facilitate catalysis when there is a need for conversion from tight binding to weak binding of a ligand during the catalytic cycle; the best-documented example of an alternating-sites mechanism is in ATP synthases [31] .
Although more difficult to demonstrate in mercuric ion reductase, studies are currently underway to evaluate the role of site-site interactions in the catalytic mechanism of this enzyme.
Perspectives
Although risky, the strategy of importing toxic Hg(II) to eliminate it is worth the risk because the unique chemical properties of Hg(0) more effectively remove it from the environment of the organism than complexation or simple exportation. However, the risk demands fine tuning of the pathway proteins for the most efficient detection and handing-off to the final detoxification protein. At present, the exquisite design for detection and regulation by MerR is the best-understood part of the pathway. Although some important features have been identified for each of the other proteins, much work remains to develop a clear picture of how successive proteins in the path function and interact with each other to accomplish the overall goal of detoxification. 
Summary

